Nucleai Secures $14M to Enhance Clinical Trial Enrollment with Spatial AI Biomarker
What You Should Know: - Nucleai, a pioneer in spatial AI biomarkers raises $14M in funding led by M Ventures, the corporate venture arm of Merck KGaA. - The investment brings Nucleai's total funding to
Source: hitconsultant.net